Jenevieve N. Nutovits

Jenevieve Nutovits is an Associate in Goodwin’s Intellectual Property Litigation practice who focuses her practice on intellectual property and complex commercial matters on behalf of life sciences and technology companies. Her practice includes representing clients in patent infringement, trade secret and copyright misappropriation, and licensing disputes covering a wide range of innovative industries, including electronic devices, pharmaceuticals, biotech, and consumer products.

Jenevieve also focuses part of her practice representing life sciences and technology companies in complex, commercial arbitrations, involving licensing, collaboration, and supply agreement disputes. Her experience also includes representing life science companies in litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA).

While in law school, Jenevieve was a legal intern in the Health Care Bureau of the New York State Attorney General’s Office. She was a Senior Articles Editor for the Georgetown Law Technology Review and served as the Director of Patents for the Student Intellectual Property Law Association.

Jenevieve is a member of the New York Intellectual Property Law Association (NYIPLA) Patent Litigation and Women in IP Law Committees.

Jenevieve was named a Recommended Lawyer by the Legal 500 US in 2024 for her work in Trade Secrets.

Jenevieve is a contributor to the firm’s Big Molecule Watch, an award-winning blog that reports real-time analysis and updates on regulatory issues, litigation, legislation, and other news in the developing world of biosimilars. She is also a contributor to Goodwin’s PTAB Trial Tracker. Jenevieve’s recent publications include:

• Co-Author, “Watch out §101, the USPTO has a New Sheriff in Town,” Goodwin Client Alert, October 2025